Brain-computer interface (BCI) technology, which routes neural signals from a person's head to a computer, has transitioned from science fiction to a highly competitive segment of the tech industry. Among the companies at the forefront of commercializing BCI is Neurable, which recently announced its strategy to license its advanced “mind-reading” technology to a wide array of consumer wearables.

Neurable distinguishes itself through its focus on “non-invasive” BCI. Unlike companies such as Neuralink, founded by Elon Musk, which requires surgical implantation of computer chips, Neurable’s product allows users to benefit without undergoing brain surgery. The company's technology operates by combining EEG sensors with sophisticated signal processing, enabling it to scan a user’s brain activity. This data is then analyzed using artificial intelligence (AI) to provide comprehensive information about an individual’s cognitive performance.

In December, Neurable secured $35 million in a Series A funding round, earmarked for scaling the commercialization of its technology. As part of this expansion, the company is actively seeking to license its brain-sensing technology to various consumer-facing companies. The vision is to integrate this mind-reading tech, which delivers detailed insights into brain function during different activities, into existing wearables across diverse sectors. These include health and athletic products, productivity tools, and gaming.

According to a company press release, Neurable's licensing platform empowers Original Equipment Manufacturers (OEMs) to seamlessly embed its AI-powered brain-sensing technology into their hardware, such as headphones, hats, glasses, and headbands. This approach allows OEMs to maintain full autonomy over product design, user experience, and distribution. Neurable has already established partnerships to validate its technology's effectiveness. One notable collaboration is with HP Inc.’s HyperX, a prominent gaming brand, which resulted in a headset designed to help gamers enhance focus and optimize performance. Additionally, Neurable has partnered with iMotions, a software platform specializing in human behavior research, to support its research initiatives.

Ramses Alcaide, Neurable’s CEO, indicated that while he couldn't disclose new partnerships, the company is actively expanding its reach across numerous domains. Alcaide explained that Neurable previously focused on specific partnerships to prove the viability of unique commercial applications. Now, having demonstrated broad applicability, the startup is concentrating on scaling its technology, aiming for it to become as ubiquitous as heart rate sensors. “What we’re doing now is we’re basically saying, like, ‘Hey, we’ve demonstrated that we’re getting great traction’,” Alcaide stated, envisioning widespread adoption.

Given the intimate nature of brain data compared to information from a heart rate sensor, privacy is a critical concern. Alcaide assured that Neurable prioritizes user data protection through anonymization and encryption. He highlighted the company's adherence to HIPAA standards, noting that they have gone “above and beyond where a lot of startups would be at our stage” to safeguard data. Regarding the use of neural data for AI software training, Alcaide clarified that this only occurs with explicit user consent and in a very specific, targeted manner, for particular experiments, rather than indiscriminate collection and training.

Alcaide believes the industry is at an “inflection point,” where a scalable and viable business model in neuro-technology has finally emerged. The subsequent evolution of this exciting field remains a pivotal question.